Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer-Reference-Cited by-同舟云学术

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer

Published:2018-03 Issue:2 Volume:19 Page:191-198
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Gobbini Elisa,Pilotto Sara,Pasello Giulia,Polo Valentina,Di Maio Massimo,Arizio Francesca,Galetta Domenico,Petrillo Patrizia,Chiari Rita,Matocci Roberta,Di Costanzo Alessandro,Di Stefano Teresa Severina,Aglietta Massimo,Cagnazzo Celeste,Sperduti Isabella,Bria Emilio,Novello Silvia

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. European cancer mortality predictions for the year 2016 with focus on leukaemias;Malvezzi;Ann Oncol,2016

2. Unbiased, relevant, and reliable assessments in health care: important progress during the past century, but plenty of scope for doing better;Chalmers;BMJ,1998

3. The role of clinical trial participation in cancer research: barriers, evidence, and strategies;Unger;Am Soc Clin Oncol Educ Book,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety risk of information overload and bureaucracy in oncology clinical trial conduct;European Journal of Cancer;2023-04

2. Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trials;Annals of Oncology;2023-01

3. New trends in clinical trials—between complexity and the need for renewal;AboutOpen;2022-06-21

4. Zusammenarbeit mit klinischen Auftragsforschungsinstituten;Der Ophthalmologe;2021-12-18

5. ESMO Clinical Research Observatory (ECRO): improving the efficiency of clinical research through rationalisation of bureaucracy;ESMO Open;2020